Dilek Sönmezer Açıkgöz | Tissue engineering | Best Researcher Award

Posted on by ScienceFather

Dr. Dilek Sönmezer Açıkgöz | Tissue engineering | Best Researcher Award

Phd at Çukurova University, Turkey

Dr. Dilek Sönmezer Açıkgöz is a Lecturer at Çukurova University’s Department of Biomedical Engineering, specializing in biomaterials, tissue engineering, and regenerative medicine. She holds a PhD from Erciyes University and has contributed to cutting-edge research on pericardial fluid applications in tissue engineering. Dr. Sönmezer has published extensively in SCI-indexed journals and presents regularly at international conferences.

Publication Profile

orcid

🎓 Education

PhD: Biomedical Engineering, Erciyes University (2012-2022)MSc: Biomedical Engineering, Erciyes University (2008-2011)BSc: Biology, Erciyes University (2004-2008)Internship: Eindhoven University of Technology (2010-2011)

💼 Experience

Lecturer: Çukurova University (2014-present)Research: Tissue engineering, pericardial fluid characterization, biomaterial developmentPatent Holder: Ultrasonic system for coronary bypass surgery

🏆 Awards & Honors

Patent: Ultrasonic vascular measurement system (2015)Key Publications: Bio-Medical Materials and Engineering, Biotechnology Applied BiochemistryRecognitions: Frequent presenter at international biomedical conferences

🔬 Research Focus

Biomedical Engineering: Biomaterials, tissue engineering, pericardial fluid studiesBioprinting: Developing biocompatible bioinks for 3D printingRegenerative Medicine: Exploring extracellular matrix applications for tissue regeneration

Publications 📖

Applications of a Biocompatible Alginate/Pericardial Fluid-Based Hydrogel for the Production of a Bioink in Tissue Engineering
Biotechnology and Applied Biochemistry | 2024-12-02
DOI: 10.1002/bab.2697
Contributors: Dilek Sönmezer Açıkgöz, Fatma Latifoğlu, Güler Toprak, Münevver Baran

Production of Hydrogel with Alginate and Pericardial Fluid for Use in Tissue Engineering Applications
Çukurova Üniversitesi Mühendislik Fakültesi Dergisi | 2023-12-28
DOI: 10.21605/cukurovaumfd.1410697
Contributors: Dilek Sönmezer, Fatma Latifoğlu

A Native Extracellular Matrix Material for Tissue Engineering Applications: Characterization of Pericardial Fluid
Journal of Biomedical Materials Research Part B: Applied Biomaterials | 2023-09
DOI: 10.1002/jbm.b.35260
Contributors: Dilek Sönmezer, Fatma Latifoğlu, Güler Toprak, Münevver Baran

 

Conclusion

Dr. Dilek Sönmezer Açıkgöz stands out as a highly qualified candidate for the Best Researcher Award, with substantial contributions to biomedical engineering, tissue engineering, and biomaterials. Her dedication to research, publications in top journals, and development of patented technology make her a strong contender. Strengthening international partnerships and focusing on high-impact translational research can further enhance her candidacy for future recognitions.

Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Posted on by ScienceFather

Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Dr at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Liang Yang, MD, is a 33-year-old orthopedic surgeon at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, China. Specializing in biomimetic materials for orthopedic reconstruction, he focuses on repairing bone defects under pathological conditions like osteoporosis. His innovative work on hydroxyapatite (HA) modification and chiral-engineered biomaterials has led to significant advancements in bone healing and regeneration.

Publication Profile

orcid

🎓 Education

Liang Yang earned his MD in Orthopedics from Shanghai Jiao Tong University School of Medicine. His academic pursuits have centered on advancing orthopedic materials, particularly through modifying HA to enhance bioactivity. Yang’s education combined intensive clinical training with cutting-edge research on bioactive ion doping (Sr2+/Fe3+) in HA for bone regeneration, culminating in impactful publications and novel biomaterial development. His studies positioned him at the forefront of orthopedic biomimetics.

💼 Experienc

Dr. Yang has dedicated his career to orthopedic surgery and biomaterial research at Shanghai Sixth People’s Hospital. His expertise spans developing bioactive hydroxyapatite materials, pioneering chiral-engineered biomaterials, and addressing osteoporosis-induced bone defects. Yang has led multiple research projects, resulting in publications in high-impact journals. His work reflects a seamless blend of surgical practice and translational research, bridging the gap between clinical needs and innovative material solutions.

🏆 Awards and Honors

Dr. Yang’s contributions to orthopedic biomaterials have earned him recognition in scientific and medical communities. His publications in journals like Advanced Science and Chem. Eng. J. have been widely cited. He received institutional awards for innovation in biomimetic material development and recognition from Shanghai Jiao Tong University for advancing orthopedic reconstruction techniques. His groundbreaking work on chiral hydroxyapatite further positioned him as a leader in biomaterial innovation.

🔬 Research Focus

Liang Yang’s research focuses on biomimetic materials for orthopedic reconstruction, particularly hydroxyapatite (HA) modification to enhance bioactivity and bone regeneration. His work explores doping HA with Sr2+/Fe3+ ions to modulate immunoregulation, angiogenesis, and osteogenesis. Recently, Yang synthesized chiral hydroxyapatite (CHA) with enantiomer-dependent osseointegration properties, unveiling L-CHA’s superior potential for osteoporosis treatment. His research paves the way for next-gen chiral-engineered biomaterials in orthopedics.

Publications 📖

Chirality‐Induced Hydroxyapatite for Osteoporotic Osseointegration – Advanced Science, 2024. DOI: 10.1002/advs.202411602.

Focus: Enantioselective bone-implant interactions to enhance osseointegration in osteoporosis.

Graphene Oxide Quantum Dot Scaffold – Advanced Functional Materials, 2023. DOI: 10.1002/ADFM.202211709.

Focus: Immuno-inductive angiogenesis and nerve regeneration via biocompatible nanoscaffolds.

Cryogenically 3D Printed Biomimetic Scaffolds – Chemical Engineering Journal, 2022. DOI: 10.1016/J.CEJ.2021.133459.

Focus: Bone tissue engineering using Sr2+/Fe3+ doped hydroxyapatite scaffolds.

Biomimetic Porous Scaffolds – Biomedical Materials, 2022. DOI: 10.1088/1748-605X/ac4b45.

Focus: Accelerated angiogenesis/osteogenesis with doped hydroxyapatite.

3D Printed Porous Scaffolds for Bone Tissue – Biofabrication, 2021. DOI: 10.1088/1758-5090/ABCF8D.

Focus: Bioactive scaffolds enhancing bone regeneration.

Anterior Acetabular Fracture Fixation – BMC Musculoskeletal Disorders, 2021. DOI: 10.1186/S12891-021-04034-W.

Focus: Surgical fixation methods for acetabular fractures.

Cartilage Changes with Glucocorticoids – Cartilage, 2021. DOI: 10.1177/1947603520978574.

Focus: Epiphyseal cartilage effects in glucocorticoid-treated mice.

🔹 Conclusion

Dr. Liang Yang’s pioneering work in chiral hydroxyapatite and bioactive bone materials makes him a strong contender for the Best Researcher Award. His contributions to orthopedic biomaterials, innovative solutions for bone defects, and significant publication record underscore his potential to drive transformative advancements in orthopedic surgery and bone regeneration.

Aurélien Chendjou Kamela | Hématologie | Best Researcher Award

Posted on by ScienceFather

Mr. Aurélien Chendjou Kamela | Hématologie | Best Researcher Award

Technicien Classe B at , CISSS Chaudière-appalaches, Canada

A seasoned health sciences professional, this individual has over 5 years of experience in research and project management. With a strong background in clinical planning and support, they have gained a solid reputation in hematology, particularly in sickle cell and hemophilia research. Their expertise has been instrumental in implementing screening and awareness campaigns across Cameroon, and they have contributed significantly to scientific publications and research protocols. Currently a lab technician at CISSS Chaudière-Appalaches, they continue to build on their experience while advancing in functional genomics at Université Laval.

Publication Profile

orcid

Education 🎓

They began their academic journey with a BSc in Biology of Animal Organisms (2012–2015) from Université de Yaoundé I. To further specialize, they pursued a Master’s in Medical Hematology (2020–2022) from the same university, which laid the foundation for their deep focus on blood disorders. Eager to stay at the forefront of scientific advancements, they are now expanding their expertise through a Microprogram in Functional Genomics (2023–2024) at Université Laval. This diverse educational path equips them with both theoretical knowledge and practical skills essential for their research roles in health sciences.

Experience 🔬

They currently work as a Lab Technician (2024–present) at CISSS Chaudière-Appalaches, where they manage specimen preparation, inventory, and laboratory data. Prior to this, they were the Project Manager for Screening/Diagnosis (2021–2023) at GEDREPACAM, leading neonatal screening and public health initiatives for sickle cell disease. Their role as a Research Student (2017–2022) at the Hemophilia Treatment Center in Yaoundé honed their ability to manage research projects independently. They’ve also coordinated biological diagnostics at IECD (2021) and handled data entry for the same organization (2019–2021). Their diverse professional background reflects a balance of research, clinical work, and project management.

Awards and Honors 🏅

Their research has earned recognition through multiple grants from the World Federation of Hemophilia. In 2022, they secured funding for their project evaluating the quality of life of hemophilia patients under prophylactic treatment in Cameroon. They were also the Principal Investigator for the Hemophilia Treatment Center financing program (2021 and 2022 editions), backed by the same federation. These awards underscore their dedication to improving the healthcare landscape for hemophilia patients, particularly in resource-limited settings. Their ability to secure funding reflects their expertise in both research and project execution, enhancing their reputation in the field.

Research Focus🔬 

Their research primarily centers on blood disorders like hemophilia and sickle cell disease. They have been involved in evaluating quality-of-life measures for hemophilia patients, especially those under prophylactic treatment in Cameroon. They are also skilled in managing and analyzing clinical samples, devising new diagnostic protocols, and publishing scientific findings. Their research contributions extend to the screening and prevention of sickle cell disease, where they have led initiatives in public health campaigns. This individual also plays a key role in educating and training future researchers, ensuring that their expertise is passed on to the next generation

Publication  Top Notes

Biological Abnormalities of Hemostasis in Patients with Epistaxis or Menorrhagia in Yaoundé, Cameroon

Conclusion

The candidate is well-suited for the Research for Best Researcher Award due to their strong educational background, significant contributions to hematology and sickle cell disease research, and proven project management skills. Their ability to secure international funding, publish research, and contribute to public health initiatives reflects their commitment to advancing the medical sciences. With a focus on expanding their research portfolio and further enhancing international collaboration, they have the potential to achieve even greater success in the field of health science research.

Baolei Guo | Vascular Surgery | Best Researcher Award

Posted on by ScienceFather
Assoc Dr.  Department of Vascular Surgery, Zhongshan Hospital Fudan University, china

Dr. Baolei Guo is an Associate Professor at Fudan University and an Attending Doctor in the Department of Vascular Surgery at Zhongshan Hospital, Fudan University, where he has served since 2017. He earned his MD and Ph.D. from Shanghai Medical College, Fudan University, and has been involved in numerous research projects, focusing on vascular surgery, medical imaging, and device development. Dr. Guo has received multiple prestigious grants, including the Health Youth Talent Training Program and the National Natural Science Foundation of China Youth Fund. His work is published in top journals, highlighting innovations in vascular surgery and imaging techniques.

 

Professional Profiles:

Scopus

 

🏢 Employment

Associate Professor, Fudan University (03/2023-present)Attending Doctor, Department of Vascular Surgery, Zhongshan Hospital Fudan University (10/2020-present)Resident Doctor, Department of Vascular Surgery, Zhongshan Hospital Fudan University (07/2017-10/2020)Resident Doctor, Department of Anesthesiology, Zhongshan Hospital Fudan University (07/2013-09/2014)

🎓 Education Experience

Shanghai Medical College, Fudan UniversityMD, PhD (2014-2017)Department of Chemical Engineering, Imperial College LondonPhD Visiting Scholar (2016-2017)Shanghai Medical College, Fudan UniversityMSc (2010-2013)Hebei Chengde Medical CollegeBSc (2005-2010)

💰 Current Grants

Health Youth Talent Training Program of Shanghai Municipal Health Commission2022YQ013, 2023/01-2025/12, 300,000¥, PIShanghai “Medical Academy Rising Star” Youth Medical Talent Training Funding ProgramR2021-016, 2022/01-2024/12, 100,000¥, PI

Dr. Baolei Guo for the Best Researcher Award

Strengths for the Award:

  1. Extensive Research and Publications: Dr. Baolei Guo has an impressive record of publications in prestigious journals like European Journal of Vascular and Endovascular Surgery, Journal of Vascular Surgery, and IEEE Transactions on Biomedical Engineering. His research primarily focuses on vascular surgery, particularly on aortic dissection, endovascular repair, and imaging technologies, which are highly relevant to advancements in vascular health.
  2. Leadership in Research Projects: As the Principal Investigator (PI) for multiple significant grants, Dr. Guo has demonstrated strong leadership and innovation in his field. His involvement in pioneering projects such as the study of PET-CT/4D-PCMR combined with IVUS multimodal imaging technology and the development of plaque surface cleaning devices during CAS highlights his commitment to improving surgical outcomes and patient care.
  3. International Collaboration and Recognition: Dr. Guo’s international experience as a visiting scholar at Imperial College London, coupled with his collaboration with researchers globally, underlines his recognition in the academic community. This global perspective enhances the impact and applicability of his research in diverse healthcare settings.
  4. Clinical Expertise: With extensive clinical experience as an attending and resident doctor in vascular surgery, Dr. Guo bridges the gap between research and practice. His work directly influences clinical procedures, making his research highly translational and impactful.
  5. Innovative Approach: Dr. Guo’s research integrates advanced imaging techniques and computational modeling, contributing to the development of cutting-edge technologies in vascular surgery. His work on creating a swine model for type B aortic dissection and his studies on the hemodynamics of vascular diseases exemplify his innovative approach.

Areas for Improvement:

  1. Broader Dissemination of Research: While Dr. Guo has a robust publication record, expanding his reach through more public-facing platforms, such as conferences, seminars, or involvement in international committees, could further enhance his visibility and influence in the global research community.
  2. Collaboration with Industry: Engaging with the medical device industry for the translation of his research into commercially viable products could significantly boost the practical application of his work. This would also open avenues for securing additional funding and enhancing the real-world impact of his research.
  3. Diversity of Research Topics: While Dr. Guo has established expertise in vascular surgery, exploring related fields such as cardiovascular biomaterials or regenerative medicine could diversify his research portfolio and contribute to a more comprehensive approach to vascular health.

 

✍️Publications Top Note :

  • Fauzi, M.F.M., Johari, N.H., Mokhtarudin, M.J.M., Yusoff, B.M., Guo, B.
    Fluid-Structure Interaction Modelling of Blood Flow in Peripheral Arterial Disease.
    Journal of Advanced Research in Fluid Mechanics and Thermal Sciences, 2024, 119(1), pp. 117–133.
  • Gao, P., Guo, B., Zhang, M., Dai, X., Liu, H.
    Modeling Method of Aortic Homeostasis Considering Three-Dimensional Residual Deformation.
    Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2024, 39(3), pp. 510–517.
  • Zhang, S., Guo, B., Hu, M.
    Some Reflections on Investigating the Long Term Healthy Life Quality of Acute Type B Aortic Dissection Patients.
    European Journal of Vascular and Endovascular Surgery, 2024, 67(3), pp. 524–525.
  • Guo, B., Chen, C., Li, Y., Fu, W., Zhang, W.W.
    Principles of Optimal Antithrombotic Therapy for Iliac Venous Stenting (POATIVES): A National Expert-Based Delphi Consensus Study.
    Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2024, 12(2), 101739.
  • Armour, C., Guo, B., Saitta, S., Dong, Z., Xu, X.Y.
    The Role of Multiple Re-Entry Tears in Type B Aortic Dissection Progression: A Longitudinal Study Using a Controlled Swine Model.
    Journal of Endovascular Therapy, 2024, 31(1), pp. 104–114.
  • Wang, K., Armour, C.H., Guo, B., Dong, Z., Xu, X.Y.
    A New Method for Scaling Inlet Flow Waveform in Hemodynamic Analysis of Aortic Dissection.
    International Journal for Numerical Methods in Biomedical Engineering, 2024.

Conclusion:

Dr. Baolei Guo stands out as a strong candidate for the Best Researcher Award due to his significant contributions to vascular surgery research, his leadership in innovative projects, and his integration of clinical expertise with research. By expanding his research dissemination efforts and fostering collaborations with industry, Dr. Guo could further elevate his impact in the field. His work not only advances scientific knowledge but also directly improves patient outcomes, making him a deserving contender for this prestigious award.

Prof Dr. Xinwu Lu | Biomedicine | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Xinwu Lu | Biomedicine | Best Researcher Award

Prof Dr. Xinwu Lu, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China

Dr. Xinwu Lu, MD, Ph.D., is a distinguished Professor of Vascular Surgery and Chief Surgeon at the Department of Vascular Surgery, Shanghai Ninth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With extensive training from Shanghai Jiao Tong University and Amsterdam University Medical Centres, he is renowned for his expertise in vascular surgery and epidemiology. Dr. Lu holds key leadership roles including Chairman of the Shanghai Jiao Tong University Vascular Disease Forum and Director of the Vascular Disease Center. He has authored over 200 papers, holds 41 patents, and serves on numerous editorial boards, impacting vascular surgery globally with a focus on innovative medical solutions.

Professional Profiles:

Scopus

🎓 Education and Training

Shanghai Jiao Tong University School of Medicine, ChinaM.D. (1998) – Vascular SurgeryPh.D. (2004) – Vascular SurgeryAmsterdam University Medical Centres, NetherlandsVisiting Scholar (2005) – Epidemiology, Vascular SurgeryLeipzig University, GermanyVisiting Scholar (2013) – Vascular Surgery

🏅 Leadership Roles and Professional Memberships

Chairman, Shanghai Jiao Tong University Vascular Disease Forum (SJVF)Director, Shanghai Jiao Tong University Vascular Disease CenterFirst Vice President, Vascular Surgery Committee of Shanghai Medical AssociationFirst Vice President, Vascular Surgery Committee of Shanghai Physicians AssociationPresident, Vascular Malformations Committee of Chinese Medical Doctor AssociationPresident, Vascular Malformations Committee of Traditional Chinese Medicine AssociationPresident, Peripheral Vascular Committee of Chinese Medicine Intervention AssociationMember, The American Society for Vascular Surgery (SVS)Member, The European Society for Vascular Surgery (ESVS)

📚 Editorial and Reviewer Roles

Editorial board member and reviewer for 14 SCI journals (including AVS, Biomaterials, JVS, EJVES, etc.)Reviewer for 10 Chinese journals (including Chinese Medical Journal, Chinese Journal of Surgery, Chinese Journal of General Surgery, Chinese Journal of Experimental Surgery, etc.)

👨‍⚕️ Professional Positions

1998 – 2004: Attending Doctor, Department of Vascular Surgery, Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

✍️Publications Top Note :

Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway

Authors: Chen, K., Jin, H.-J., Wu, Z.-H., Lu, X.-W., Zheng, X.-T.
Journal: Molecular Medicine, 2024, 30(1), 58

Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with venous thromboembolism: protocol of a systematic review and meta-analysis

Authors: Fu, Y., Pu, H., Wang, Y., Hu, M., Cheng, Y.
Journal: BMJ Open, 2024, 14(3), e074547

Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study

Authors: Lei, J., Pu, H., Zhang, L., Wang, R., Lu, X.
Journal: Catheterization and Cardiovascular Interventions, 2024, 103(5), pp. 752–757

Integrative multi-omics analyses reveal vesicle transport as a potential target for thoracic aortic aneurysm

Authors: Lei, J., Qiu, P., Wu, Z., Xu, Z., Lu, X.
Journal: Computers in Biology and Medicine, 2024, 170, 108071

Dynamin-related protein 1 mediates the therapeutic effect of isoliquiritigenin in diabetic intimal hyperplasia via regulation of mitochondrial fission

Authors: Zhang, B.-F., Wu, Z.-H., Chen, K., Lu, X.-W., Zheng, X.-T.
Journal: Hypertension Research, 2024

Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins

Authors: Yang, X., Jin, J., Huang, S., Ye, K., Lu, X.
Journal: Vascular, 2024

Development and validation of a nomogram for identifying venous thromboembolism following oral and maxillofacial oncological surgery with simultaneous reconstruction

Authors: Wang, X., Chen, S., Sun, L., Lu, X., Ding, A.
Journal: European Journal of Surgical Oncology, 2024, 50(1), 107307

CDKN2B-AS1 mediates proliferation and migration of vascular smooth muscle cells induced by insulin

Authors: Jin, H.-J., Wu, Z.-H., Zhang, B.-F., Wang, W.-T., Zheng, X.-T.
Journal: Cell and Tissue Research, 2023, 394(3), pp. 455–469

Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis

Authors: Pu, H., Song, J., He, Z., Lu, X., Liu, G.
Journal: Thrombosis Journal, 2023, 21(1), 96

An H2S-BMP6 Dual-Loading System with Regulating Yap/Taz and Jun Pathway for Synergistic Critical Limb Ischemia Salvaging Therapy

Authors: Hu, J., Xu, Z., Liao, D., Liu, X., Li, B.
Journal: Advanced Healthcare Materials, 2023, 12(28), 2301316

Dr. Yongyue Wei | based Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Yongyue Wei | based Medicine | Best Researcher Award 

Dr. Yongyue Wei , Peking University, China

Dr. Yongyue Wei is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Orcid

Google scholar

Scopus

🎓 Education

Bachelor’s Degree: Yanbian University (2014-2019)MD: Yanbian University (2020-2022)PhD: Yanbian University (2022-present)

💼 Professional Experiences

No Professional Experience Listed🏅 Honors and Awards2024: Best Moderated Poster Presentation Award, Korean Society of CardioMetabolic Syndrome, Asia-Pacific CardioMetabolic Syndrome Congress

🔬 Major Research Interests

Pulmonary Hypertension 🌬️Chronic Stress-Related Diseases 😰Nutrition 🍎Atherosclerosis & Vascular Biology 💓

📖 Publications Top Note :

Rare Variants of Large Effect in BRCA2 and CHEK2 Affect Risk of Lung Cancer
Authors: Y Wang, JD McKay, T Rafnar, Z Wang, MN Timofeeva, P Broderick, Y Wei, et al.
Journal: Nature Genetics 46 (7), 736-741, 2014
Citations: 434
Summary: This study identifies significant rare genetic variants in BRCA2 and CHEK2 that substantially increase the risk of lung cancer, highlighting critical pathways for targeted therapies.

Development and Validation of an Immune Gene-Set Based Prognostic Signature in Ovarian Cancer
Authors: S Shen, G Wang, R Zhang, Y Zhao, H Yu, Y Wei, F Chen
Journal: EBioMedicine 40, 318-326, 2019
Citations: 214
Summary: The research develops a prognostic signature based on immune gene sets, providing a robust tool for predicting ovarian cancer outcomes and personalizing treatment strategies.

Comparison of the Prevalence and Changing Resistance to Nalidixic Acid and Ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009
Authors: B Gu, Y Cao, S Pan, L Zhuang, R Yu, Z Peng, H Qian, Y Wei, L Zhao, et al.
Journal: International Journal of Antimicrobial Agents 40 (1), 9-17, 2012
Citations: 185
Summary: This comparative study examines the resistance patterns of Shigella to nalidixic acid and ciprofloxacin across different continents, shedding light on global antimicrobial resistance trends.

Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy
Authors: Y Wang, H Zhu, X Hou, Z Wang, F Zou, Z Qian, Y Wei, X Wang, L Zhang, et al.
Journal: Journal of the American College of Cardiology 80 (13), 1205-1216, 2022
Citations: 157
Summary: This clinical trial compares the efficacy of left bundle branch pacing with biventricular pacing in cardiac resynchronization therapy, offering new insights for treatment optimization.

Risk Factors and Long-Term Health Consequences of Macrosomia: A Prospective Study in Jiangsu Province, China
Authors: S Gu, X An, L Fang, X Zhang, C Zhang, J Wang, Q Liu, Y Zhang, Y Wei, et al.
Journal: Journal of Biomedical Research 26 (4), 235-240, 2012
Citations: 126
Summary: This prospective study investigates the risk factors for macrosomia and its long-term health impacts, providing valuable data for preventive healthcare strategies.

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Authors: G Fehringer, P Kraft, PD Pharoah, RA Eeles, N Chatterjee, Y Wei, et al.
Journal: Cancer Research 76 (17), 5103-5114, 2016
Citations: 117
Summary: A genome-wide analysis identifying pleiotropic genetic associations across multiple cancer types, enhancing understanding of common pathways in carcinogenesis.

Gene Control of Tyrosine Kinase TIE2 and Vascular Manifestations of Infections
Authors: CC Ghosh, S David, R Zhang, A Berghelli, K Milam, SJ Higgins, J Hunter, Y Wei, et al.
Journal: Proceedings of the National Academy of Sciences 113 (9), 2472-2477, 2016
Citations: 104
Summary: The study explores the role of TIE2 in vascular responses to infections, providing insights into the mechanisms of vascular diseases and potential therapeutic targets.

Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study
Authors: T Wang, Z Liu, Z Wang, M Duan, G Li, S Wang, W Li, Z Zhu, Y Wei, et al.
Journal: PLoS One 9 (4), e94124, 2014
Citations: 83
Summary: This international study links thrombocytopenia with higher mortality in acute respiratory distress syndrome (ARDS), emphasizing the importance of platelet count monitoring.

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Authors: R Huang, Y Wei, RJ Hung, G Liu, L Su, R Zhang, X Zong, ZF Zhang, et al.
Journal: EBioMedicine 2 (11), 1677-1685, 2015
Citations: 72
Summary: This pooled analysis investigates the associations between smoking, COPD, and small cell lung cancer, underscoring the interconnected risk factors in lung cancer development.

Comprehensive Analyses of m6A Regulators and Interactive Coding and Non-Coding RNAs Across 32 Cancer Types
Authors: S Shen, R Zhang, Y Jiang, Y Li, L Lin, Z Liu, Y Zhao, H Shen, Z Hu, Y Wei, et al.
Journal: Molecular Cancer 20, 1-6, 2021
Citations: 69
Summary: This study comprehensively analyzes m6A regulators and their interactions with coding and non-coding RNAs across multiple cancer types, providing a deeper understanding of epigenetic regulation in cancer.